SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000921895-21-001835
Filing Date
2021-07-09
Accepted
2021-07-09 16:44:33
Documents
1
Period of Report
2021-07-02

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT form312566003_07092021.html 3  
1 OWNERSHIP DOCUMENT form312566003_07092021.xml 3 5664
  Complete submission text file 0000921895-21-001835.txt   7264
Mailing Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142 617-514-7149
Summit Therapeutics Inc. (Issuer) CIK: 0001599298 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O SUMMIT THERAPEUTICS INC. ONE BROADWAY, 14TH FLOOR CAMBRIDGE MA 02142
Business Address
Maranian Jeffrey R (Reporting) CIK: 0001871604 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36866 | Film No.: 211083258